CASTLE BIOSCIENCES INC
For the period ended Feb 27, 2025. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Feb 27, 2025 · Filed Feb 27, 2025
Use the contents to explore the available documents and sections.
CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Three Months EndedDecember 31, | Twelve Months EndedDecember 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| (unaudited) · (unaudited) | ||||
| NET REVENUES | $86,311 | $66,120 | $332,069 | $219,788 |
| OPERATING EXPENSES AND OTHER OPERATING INCOME | ||||
| Cost of sales (exclusive of amortization of acquired intangible assets) | 16,183 | 12,423 | 60,205 | 44,982 |
| Research and development | 11,773 | 12,994 | 52,041 | 53,618 |
| Selling, general and administrative | 49,965 | 44,090 | 200,047 | 180,152 |
| Amortization of acquired intangible assets | 4,340 | 2,271 | 11,106 | 9,013 |
| Total operating expenses, net | 82,261 | 71,778 | 323,399 | 287,765 |
| Operating income (loss) | 4,050 | (5,658) | 8,670 | (67,977) |
| Interest income | 3,372 | 3,119 | 12,916 | 10,623 |
| Changes in fair value of trading securities | 555 | — | 555 | — |
| Interest expense | (92) | (2) | (577) | (11) |
| Income (loss) before income taxes | 7,885 | (2,541) | 21,564 | (57,365) |
| Income tax (benefit) expense | (1,705) | 39 | 3,319 | 101 |
| Net income (loss) | $9,590 | $(2,580) | $18,245 | $(57,466) |
| Earnings (loss) per share: | ||||
| Basic | $0.34 | $(0.10) | $0.66 | $(2.14) |
| Diluted | $0.32 | $(0.10) | $0.62 | $(2.14) |
| Weighted-average shares outstanding: | ||||
| Basic | 28,126 | 27,030 | 27,776 | 26,802 |
| Diluted | 30,200 | 27,030 | 29,255 | 26,802 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.